234080 — JW Life Science Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Market Cap
KR₩231bn
Enterprise Value
KR₩254bn
Revenue
KR₩222bn

Annual balance sheet for JW Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,592	5,078	28,873	28,374	9,622
Net Total Accounts Receivable
Net Total Receivables	36,578	37,198	53,772	55,731	59,862
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	56,496	64,430	105,008	107,834	105,664
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	135,423	137,145	131,555	124,577	132,051
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	218,041	219,467	252,942	255,836	325,324
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	69,268	83,902	80,044	94,259	80,179
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	85,980	87,975	112,610	96,443	124,879
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	132,061	131,492	140,332	159,393	200,445
Total Liabilities & Shareholders' Equity	218,041	219,467	252,942	255,836	325,324
Total Common Shares Outstanding